|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Oric Pharmaceuticals, Inc. (ORIC) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
67,050,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s clinical stage product candidates include: ORIC-533, an orally bioavailable small molecule inhibitor of CD73 which playing a role in resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-114, a brain penetrant, orally bioavailable, irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; and ORIC-944, an allosteric inhibitor of polycomb repressive complex 2 via the embryonic ectoderm development subunit.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
105,103 |
145,103 |
165,636 |
Total Sell Value |
$0 |
$1,353,228 |
$1,674,000 |
$1,738,870 |
Total People Sold |
0 |
3 |
3 |
3 |
Total Sell Transactions |
0 |
6 |
10 |
16 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Chacko Jacob |
PRESIDENT AND CEO |
|
2024-03-06 |
4 |
AS |
$16.21 |
$648,380 |
D/D |
(40,000) |
728,544 |
|
- |
|
Chacko Jacob |
PRESIDENT AND CEO |
|
2024-02-07 |
4 |
AS |
$12.30 |
$320,186 |
D/D |
(26,042) |
768,544 |
|
- |
|
Chacko Jacob |
PRESIDENT AND CEO |
|
2024-02-06 |
4 |
AS |
$12.12 |
$169,160 |
D/D |
(13,958) |
794,586 |
|
- |
|
Piscitelli Dominic |
Chief Financial Officer |
|
2023-12-15 |
4 |
S |
$8.58 |
$45,338 |
D/D |
(5,282) |
83,809 |
|
- |
|
Piscitelli Dominic |
Chief Financial Officer |
|
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,042 |
89,091 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2023-12-15 |
4 |
S |
$8.58 |
$124,813 |
D/D |
(14,539) |
808,544 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,667 |
823,083 |
|
- |
|
Multani Pratik S |
Chief Medical Officer |
|
2023-12-15 |
4 |
S |
$8.59 |
$45,351 |
D/D |
(5,282) |
23,809 |
|
- |
|
Multani Pratik S |
Chief Medical Officer |
|
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,042 |
29,091 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2023-07-11 |
4 |
AS |
$8.01 |
$41,287 |
D/D |
(5,156) |
780,652 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2023-07-10 |
4 |
AS |
$8.01 |
$84,212 |
D/D |
(10,508) |
785,808 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2023-07-05 |
4 |
AS |
$8.01 |
$34,711 |
D/D |
(4,336) |
796,316 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2023-06-26 |
4 |
AS |
$8.03 |
$160,562 |
D/D |
(20,000) |
800,652 |
|
- |
|
Pfizer Inc |
10% Owner |
|
2022-12-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,376,344 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2022-12-15 |
4/A |
S |
$3.07 |
$18,859 |
D/D |
(6,137) |
816,652 |
|
- |
|
Multani Pratik S |
Chief Medical Officer |
|
2022-12-15 |
4/A |
S |
$3.07 |
$6,846 |
D/D |
(2,227) |
7,285 |
|
- |
|
Piscitelli Dominic |
Chief Financial Officer |
|
2022-12-15 |
4/A |
S |
$3.08 |
$6,854 |
D/D |
(2,227) |
67,285 |
|
- |
|
Multani Pratik S |
Chief Medical Officer |
|
2022-12-15 |
4 |
S |
$3.25 |
$6,789 |
D/D |
(2,089) |
7,423 |
|
- |
|
Multani Pratik S |
Chief Medical Officer |
|
2022-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
9,512 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2022-12-15 |
4 |
S |
$3.25 |
$18,733 |
D/D |
(5,764) |
817,025 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2022-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,666 |
822,789 |
|
- |
|
Piscitelli Dominic |
Chief Financial Officer |
|
2022-12-15 |
4 |
S |
$3.25 |
$6,789 |
D/D |
(2,089) |
67,423 |
|
- |
|
Piscitelli Dominic |
Chief Financial Officer |
|
2022-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
69,512 |
|
- |
|
Chacko Jacob |
President and CEO |
|
2022-05-13 |
4 |
B |
$2.82 |
$214,561 |
D/D |
76,072 |
802,652 |
2.81 |
- |
|
Chacko Jacob |
President and CEO |
|
2022-05-12 |
4 |
B |
$2.75 |
$190,467 |
D/D |
69,354 |
726,580 |
2.81 |
- |
|
118 Records found
|
|
Page 1 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|